Back to Newsroom

Corbus Pharmaceuticals to Present at the 2017 Jefferies Global Healthcare Conference

NORWOOD, MA — (Marketwired) — 06/01/17 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today, Yuval Cohen, Ph.D., Chief Executive Officer, will present at the 2017 Jefferies Global Healthcare Conference on Thursday, June 8, 2017 at 3:30 p.m. ET in New York, NY.
READ MORE…